InMode Ltd. (NASDAQ:INMD - Get Free Report)'s share price dropped 3.5% during trading on Friday . The stock traded as low as $17.83 and last traded at $17.81. Approximately 216,123 shares were traded during trading, a decline of 77% from the average daily volume of 948,180 shares. The stock had previously closed at $18.46.
Wall Street Analysts Forecast Growth
INMD has been the subject of several analyst reports. Barclays raised their target price on InMode from $26.00 to $29.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 5th. Needham & Company LLC restated a "hold" rating on shares of InMode in a research report on Tuesday, February 4th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $22.25.
View Our Latest Research Report on INMD
InMode Trading Down 0.9 %
The company has a 50 day moving average price of $17.97 and a 200 day moving average price of $17.65. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of 7.74 and a beta of 2.08.
Institutional Investors Weigh In On InMode
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Quarry LP grew its stake in shares of InMode by 154.3% during the third quarter. Quarry LP now owns 3,781 shares of the healthcare company's stock worth $64,000 after purchasing an additional 2,294 shares during the period. Orion Capital Management LLC acquired a new stake in shares of InMode during the fourth quarter worth $65,000. SBI Securities Co. Ltd. acquired a new stake in shares of InMode during the fourth quarter worth $87,000. Farther Finance Advisors LLC grew its stake in shares of InMode by 26.2% during the fourth quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company's stock worth $93,000 after purchasing an additional 1,154 shares during the period. Finally, Covestor Ltd grew its stake in shares of InMode by 13.9% during the fourth quarter. Covestor Ltd now owns 5,936 shares of the healthcare company's stock worth $99,000 after purchasing an additional 723 shares during the period. 68.04% of the stock is owned by institutional investors and hedge funds.
InMode Company Profile
(
Get Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Read More
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
